News | RIVM

The spread of the UK coronavirus variant in the Netherlands

The UK variant of the coronavirus (SARS-CoV-2) has been found in 11 people in the Netherlands so far: 5 people in the Amsterdam region, 5 people in the Rotterdam region and 1 person in the Nijmegen

Improvement of air quality continues

In 2019, the calculated concentrations of nitrogen dioxide (NO2) and particulate matter (PM10) were below the European limit values in almost the whole of the Netherlands. Locally, the limit value for nitrogen dioxide is still being exceeded.

RIVM international circular economy knowledge partner

As of 7 December 2020, RIVM has become a knowledge partner of the international Platform for Accelerating the Circular Economy (PACE).

First COVID-19 vaccination in the Netherlands on 8 January 2021

If the European Medicines Agency (EMA) approves BioNTech/Pfizer’s COVID-19 vaccine next week, the first people in the Netherlands will receive the COVID-19 vaccine on Friday 8 January 2021.

First wave of COVID-19 had major impact on regular healthcare and health

During the first wave, the novel coronavirus (SARS-CoV-2) had a major impact on healthcare in the Netherlands. Many patients faced delays in appointments and treatments.

Possible start of COVID-19 vaccination in early January

If all goes well, the first people in the Netherlands will be vaccinated against COVID-19 in early January. The logistics operation aims to start vaccination in the week of 4 January 2021.

WHO Chemical Risk Assessment Workshop on new and emerging risks to human health from chemicals

RIVM is hosting an international workshop on new and emerging risks from chemicals on 20 and 21 February 2019.

Possible health risks due to exposure to chromium-6 at tROM project Tilburg

Research by RIVM shows that the participants in the so-called tROM project, their supervisors and other people involved may have been exposed to chromium-6.

Kick off European Project VITAL: Vaccines and InfecTious diseases in the Ageing popuLation

Recently, the EU-sponsored Vaccines and InfecTious diseases in the Ageing popuLation (VITAL) project was launched.